IN-HOSPITAL MORTALITY WITH NO-REFLOW DURING PRIMARY PERCUTANEOUS CORONARY INTERVENTION

K KHAN; F AKBAR; A ULLAH

doi:10.54112/bcsrj.v2023i1.543

Authors

K KHAN Department of Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan
F AKBAR Department of Cardiology, Peshawar Institute of Cardiology, Peshawar, Pakistan
A ULLAH Department of Physiology, Swat Medical College, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2023i1.543

Keywords:

Primary Percutaneous Coronary Intervention, Mortality, Reflow

Abstract

This study aimed to determine the in-hospital mortality rate associated with No Reflow During Primary Percutaneous Coronary Intervention. The study was conducted at the Peshawar Institute of Cardiology Hayatabad, Peshawar, between January 2023 and June 2023. A total of 90 patients who underwent primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) were included in the study. The incidence of no-reflow during the surgery was observed, and the death rate at six months was recorded. The mean age of the patients was 52.46±10.09 years. Out of the 90 patients, 19 (21.1%) experienced no reflow. No reflow was significantly associated with age, in-hospital mortality, and 3-point MACE (P = 0.03). The study's findings suggest that no-reflow during primary percutaneous coronary intervention is associated with a significant increase in mortality rates in the hospital setting.

Downloads

Download data is not yet available.

References

Ashraf, T., Khan, M. N., Afaque, S. M., Aamir, K. F., Kumar, M., Saghir, T., Rasool, S. I., Rizvi, S. N. H., Sial, J. A., and Nadeem, A. (2019). Clinical and procedural predictors and short-term survival of the patients with no reflow phenomenon after primary percutaneous coronary intervention. International journal of cardiology 294, 27-31.

Dubey, G., Verma, S. K., and Bahl, V. K. (2017). Primary percutaneous coronary intervention for acute ST elevation myocardial infarction: Outcomes and determinants of outcomes: A tertiary care center study from North India. Indian Heart Journal 69, 294-298.

Fajar, J. K., Heriansyah, T., and Rohman, M. S. (2018). The predictors of no reflow phenomenon after percutaneous coronary intervention in patients with ST elevation myocardial infarction: A meta-analysis. Indian Heart Journal 70, S406-S418.

Harrison, R. W., Aggarwal, A., Ou, F.-s., Klein, L. W., Rumsfeld, J. S., Roe, M. T., Wang, T. Y., and Registry, A. C. o. C. N. C. D. (2013). Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. The American journal of cardiology 111, 178-184.

Jaffe, R., Dick, A., and Strauss, B. H. (2010). Prevention and treatment of microvascular obstruction-related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. JACC: Cardiovascular Interventions 3, 695-704.

Khan, M. I., Farooq, M. U., Iqbal, H., Kazmi, S. I. A., Aqeel, I., and Khan, B. U. (2023). Effect of No-Reflow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction on Six-Month Mortality. Pakistan Journal of Medical & Health Sciences 17, 796-796.

Kumar, J., O’Connor, C. T., Kumar, R., Arnous, S. K., and Kiernan, T. J. (2019). Coronary no-reflow in the modern era: a review of advances in diagnostic techniques and contemporary management. Expert Review of Cardiovascular Therapy 17, 605-623.

Matta, A., Bouisset, F., Lhermusier, T., Campelo-Parada, F., Elbaz, M., Carrié, D., and Roncalli, J. (2020). Coronary artery spasm: new insights. Journal of Interventional Cardiology 2020.

Mazhar, J., Mashicharan, M., and Farshid, A. (2016). Predictors and outcome of no-reflow post primary percutaneous coronary intervention for ST elevation myocardial infarction. IJC Heart & Vasculature 10, 8-12.

Maznyczka, A., and Haworth, P. A. (2021). Adjunctive intracoronary fibrinolytic therapy during primary percutaneous coronary intervention. Heart, Lung and Circulation 30, 1140-1150.

Members, A. T. F., Steg, P. G., James, S. K., Atar, D., Badano, L. P., Lundqvist, C. B., Borger, M. A., Di Mario, C., Dickstein, K., and Ducrocq, G. (2012). ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). European heart journal 33, 2569-2619.

Mirbolouk, F., Gholipour, M., Salari, A., Shakiba, M., Kheyrkhah, J., Nikseresht, V., Sotoudeh, N., Moghadam, N., and Mirbolouk, M. J. (2018). CHA2DS2-VASc score predict no-reflow phenomenon in primary percutaneous coronary intervention in primary percutaneous coronary intervention. Journal of cardiovascular and thoracic research 10, 46.

Parhar, K., Millar, V., Zochios, V., Bruton, E., Jaworksi, C., West, N., and Vuylsteke, A. (2018). Clinical outcomes of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction requiring the intensive care unit. Journal of intensive care 6, 1-10.

Schwartz, B. G., and Kloner, R. A. (2012). Coronary no reflow. Journal of molecular and cellular cardiology 52, 873-882.

Sindou, M., and Mercier, P. (2018). Microvascular decompression for hemifacial spasm: outcome on spasm and complications. A review. Neurochirurgie 64, 106-116.

Su, Q., Nyi, T. S., and Li, L. (2015). Adenosine and verapamil for no‐reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. Cochrane Database of Systematic Reviews.

Sunamura, M., Ter Hoeve, N., Geleijnse, M., Steenaard, R., Van den Berg-Emons, H., Boersma, H., and Van Domburg, R. (2017). Cardiac rehabilitation in patients who underwent primary percutaneous coronary intervention for acute myocardial infarction: determinants of programme participation and completion. Netherlands Heart Journal 25, 618-628.

Tasar, O., Karabay, A. K., Oduncu, V., and Kirma, C. (2019). Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Coronary artery disease 30, 270-276.